[144] ESAB Corporation SEC Filing
ESAB Corporation submitted a Rule 144 notice disclosing a proposed sale of 4,067 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $459,760.50. The filing lists 60,698,710 shares outstanding. The securities are shown as originating from an option granted on 05/13/2019, recorded as acquired and paid in cash on 08/13/2025. The document also reports a prior sale of 1,500 shares on 06/11/2025 for $189,633.60. The filer certifies they are unaware of any undisclosed material adverse information.
ESAB Corporation ha presentato una comunicazione ai sensi della Regola 144 rivelando la proposta vendita di 4,067 azioni ordinarie tramite Fidelity Brokerage Services sul NYSE, per un valore di mercato complessivo di $459,760.50. La dichiarazione indica 60,698,710 azioni in circolazione. I titoli risultano derivare da un'opzione concessa il 05/13/2019, registrata come acquisita e pagata in contanti il 08/13/2025. Il documento riporta inoltre una precedente vendita di 1,500 azioni il 06/11/2025 per $189,633.60. Il dichiarante certifica di non essere a conoscenza di informazioni materiali negative non divulgate.
ESAB Corporation presentó un aviso conforme a la Regla 144 divulgando la propuesta de venta de 4,067 acciones ordinarias a través de Fidelity Brokerage Services en la NYSE, con un valor de mercado agregado de $459,760.50. La presentación enumera 60,698,710 acciones en circulación. Los valores figuran como originados en una opción concedida el 05/13/2019, registrada como adquirida y pagada en efectivo el 08/13/2025. El documento también informa de una venta previa de 1,500 acciones el 06/11/2025 por $189,633.60. El declarante certifica que desconoce cualquier información material adversa no divulgada.
ESAB Corporation는 규정 144에 따른 통지서를 제출하여 Fidelity Brokerage Services를 통해 4,067 보통주를 NYSE에서 총 시가로 $459,760.50에 매도할 예정임을 공시했습니다. 제출 서류에는 60,698,710 주가 발행되어 있는 것으로 기재되어 있습니다. 해당 증권은 05/13/2019에 부여된 옵션에서 기인한 것으로 표시되며, 08/13/2025에 취득 및 현금으로 지급된 것으로 기록되어 있습니다. 문서에는 또한 06/11/2025에 1,500주를 $189,633.60에 매각한 이전 거래도 보고되어 있습니다. 제출자는 공개되지 않은 중대한 불리한 정보가 없음을 인증합니다.
ESAB Corporation a déposé un avis en vertu de la Règle 144 divulguant la vente proposée de 4,067 actions ordinaires par l'intermédiaire de Fidelity Brokerage Services sur le NYSE, pour une valeur marchande totale de $459,760.50. Le dossier indique 60,698,710 actions en circulation. Les titres sont indiqués comme provenant d'une option accordée le 05/13/2019, enregistrée comme acquise et payée en espèces le 08/13/2025. Le document signale également une vente antérieure de 1,500 actions le 06/11/2025 pour $189,633.60. Le déclarant certifie ignorer toute information défavorable matérielle non divulguée.
ESAB Corporation hat eine Mitteilung gemäß Regel 144 eingereicht, in der der geplante Verkauf von 4,067 Stammaktien über Fidelity Brokerage Services an der NYSE mit einem Gesamtmarktwert von $459,760.50 offengelegt wird. Die Einreichung gibt 60,698,710 ausstehende Aktien an. Die Wertpapiere stammen demnach aus einer am 05/13/2019 gewährten Option, die als am 08/13/2025 erworben und bar beglichen verzeichnet ist. Das Dokument berichtet außerdem über einen früheren Verkauf von 1,500 Aktien am 06/11/2025 für $189,633.60. Der Einreicher bestätigt, keine nicht offengelegten wesentlichen nachteiligen Informationen zu kennen.
- Rule 144 disclosure filed, demonstrating compliance with securities transfer rules
- Sale routed through Fidelity on the NYSE, which supports transparent execution
- Insider liquidity event documented: planned sale of 4,067 shares
- Additional recent sale recorded: 1,500 shares sold on 06/11/2025 for $189,633.60
Insights
TL;DR: Insider plans to sell 4,067 shares (~$460k); prior 1,500-share sale also reported; routine Rule 144 disclosure.
The filing documents a proposed sale of 4,067 common shares via Fidelity on the NYSE with an aggregate market value of $459,760.50. It notes the shares derive from an option granted on 05/13/2019 and were recorded as acquired and paid in cash on 08/13/2025. A prior sale of 1,500 shares on 06/11/2025 for $189,633.60 is disclosed. This is a compliance-focused disclosure under Rule 144 rather than a change to operating results; no earnings or material corporate events are referenced.
TL;DR: Form 144 filed and signed representation made that no undisclosed material adverse information exists; transaction stems from option exercise.
The notice includes the standard seller representation that no undisclosed material adverse information is known. The securities to be sold are linked to an option granted in 2019, with acquisition and cash payment recorded on 08/13/2025. The filing identifies execution through a registered broker, providing transparent market routing. The disclosure is procedurally complete in the material provided, but the identity of the primary filer field is not populated in the issuer/person table of the document.
ESAB Corporation ha presentato una comunicazione ai sensi della Regola 144 rivelando la proposta vendita di 4,067 azioni ordinarie tramite Fidelity Brokerage Services sul NYSE, per un valore di mercato complessivo di $459,760.50. La dichiarazione indica 60,698,710 azioni in circolazione. I titoli risultano derivare da un'opzione concessa il 05/13/2019, registrata come acquisita e pagata in contanti il 08/13/2025. Il documento riporta inoltre una precedente vendita di 1,500 azioni il 06/11/2025 per $189,633.60. Il dichiarante certifica di non essere a conoscenza di informazioni materiali negative non divulgate.
ESAB Corporation presentó un aviso conforme a la Regla 144 divulgando la propuesta de venta de 4,067 acciones ordinarias a través de Fidelity Brokerage Services en la NYSE, con un valor de mercado agregado de $459,760.50. La presentación enumera 60,698,710 acciones en circulación. Los valores figuran como originados en una opción concedida el 05/13/2019, registrada como adquirida y pagada en efectivo el 08/13/2025. El documento también informa de una venta previa de 1,500 acciones el 06/11/2025 por $189,633.60. El declarante certifica que desconoce cualquier información material adversa no divulgada.
ESAB Corporation는 규정 144에 따른 통지서를 제출하여 Fidelity Brokerage Services를 통해 4,067 보통주를 NYSE에서 총 시가로 $459,760.50에 매도할 예정임을 공시했습니다. 제출 서류에는 60,698,710 주가 발행되어 있는 것으로 기재되어 있습니다. 해당 증권은 05/13/2019에 부여된 옵션에서 기인한 것으로 표시되며, 08/13/2025에 취득 및 현금으로 지급된 것으로 기록되어 있습니다. 문서에는 또한 06/11/2025에 1,500주를 $189,633.60에 매각한 이전 거래도 보고되어 있습니다. 제출자는 공개되지 않은 중대한 불리한 정보가 없음을 인증합니다.
ESAB Corporation a déposé un avis en vertu de la Règle 144 divulguant la vente proposée de 4,067 actions ordinaires par l'intermédiaire de Fidelity Brokerage Services sur le NYSE, pour une valeur marchande totale de $459,760.50. Le dossier indique 60,698,710 actions en circulation. Les titres sont indiqués comme provenant d'une option accordée le 05/13/2019, enregistrée comme acquise et payée en espèces le 08/13/2025. Le document signale également une vente antérieure de 1,500 actions le 06/11/2025 pour $189,633.60. Le déclarant certifie ignorer toute information défavorable matérielle non divulguée.
ESAB Corporation hat eine Mitteilung gemäß Regel 144 eingereicht, in der der geplante Verkauf von 4,067 Stammaktien über Fidelity Brokerage Services an der NYSE mit einem Gesamtmarktwert von $459,760.50 offengelegt wird. Die Einreichung gibt 60,698,710 ausstehende Aktien an. Die Wertpapiere stammen demnach aus einer am 05/13/2019 gewährten Option, die als am 08/13/2025 erworben und bar beglichen verzeichnet ist. Das Dokument berichtet außerdem über einen früheren Verkauf von 1,500 Aktien am 06/11/2025 für $189,633.60. Der Einreicher bestätigt, keine nicht offengelegten wesentlichen nachteiligen Informationen zu kennen.
FAQ
What does the Form 144 filed by ESAB (ESAB) disclose?
The filing discloses a proposed sale of 4,067 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $459,760.50.
Who is identified as selling shares in the filing?
The table reporting sales during the past three months names Rhonda L. Jordan as the seller of 1,500 shares on 06/11/2025; the primary filer/person field for the proposed sale is not explicitly populated in the issuer/person table provided.
When and how were the shares being sold acquired?
The securities to be sold are listed as acquired on 08/13/2025 with the nature of acquisition shown as Option Granted - 05/13/2019, and payment noted as cash on 08/13/2025.
How many ESAB shares outstanding does the filing show?
The filing lists 60,698,710 shares outstanding.
What prior sale of the issuer's shares is reported in the filing?
The document reports a sale of 1,500 shares on 06/11/2025 with gross proceeds of $189,633.60.
